Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foscenvivint in Liver Cirrhosis Due to HIV/HCV Co-infection in Hemophilia
NCT07681089Phase 2Recruiting
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of foscenvivint in Liver cirrhosis (LC). Started Oct 2026; status: recruiting.
02
Drugs
foscenvivint
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT07681089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07681089.